A novel model for genetic variation modulating aryl hydrocarbon receptor (AHR) function: SNP-dependent cyp1a1 induction

被引：0
|
作者：
Liu, Duan [1 ,2 ]
Kalari, Krishna R. [3 ]
Wang, Liewei [1 ,2 ]
Weinshilboum, Richard [1 ,2 ]
机构：
[1] Mayo Clin, Dept Mol Pharmacol, Rochester, MN USA
[2] Mayo Clin, Dept Expt Therapeut, Rochester, MN USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
DRUG METABOLISM REVIEWS | 2016年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P219
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [21] Aryl hydrocarbon receptor-mediated Cyp1a1 expression is modulated in a CLOCK-dependent circadian manner
    Tanimura, Naomi
    Kusunose, Naoki
    Matsunaga, Naoya
    Koyanagi, Satoru
    Ohdo, Shigehiro
    TOXICOLOGY, 2011, 290 (2-3) : 203 - 207
  • [22] Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls
    Suh, JH
    Kang, JS
    Yang, KH
    Kaminski, NE
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 187 (01) : 11 - 21
  • [23] Expression of aryl hydrocarbon receptor (AhR) and aryl hydrocarbon receptor nuclear translocator (Arnt) in adult rabbits known to be non-responsive to cytochrome P-450 1A1 (CYP1A1) inducers
    Takahashi, Y
    Nakayama, K
    Shimojima, T
    Itoh, S
    Kamataki, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 242 (03): : 512 - 518
  • [24] Tanshinone Ia is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
    Han, EH
    Kim, JY
    Oh, DH
    Shin, DW
    Cho, YN
    Woo, ER
    Jeong, HG
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 212 - 212
  • [25] Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China
    Ma, Jing-Xin
    Zhang, Kai-Li
    Liu, Xu
    Ma, Yan-Lu
    Pei, Li-Na
    Zhu, Yi-Fang
    Zhou, Lei
    Chen, Xiao-Yan
    Kong, Qing-You
    Li, Hong
    Liu, Jia
    CANCER LETTERS, 2006, 240 (02) : 253 - 260
  • [26] The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathway
    Knebel, Constanze
    Heise, Tanja
    Zanger, Ulrich M.
    Lampen, Alfonso
    Marx-Stoelting, Philip
    Braeuning, Albert
    FOOD AND CHEMICAL TOXICOLOGY, 2019, 123 : 481 - 491
  • [27] The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
    H P Ciolino
    G C Yeh
    British Journal of Cancer, 1999, 79 : 1340 - 1346
  • [28] Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor
    Ciolino, HP
    Daschner, PJ
    Yeh, GC
    CANCER RESEARCH, 1998, 58 (24) : 5707 - 5712
  • [29] The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
    Ciolino, HP
    Yeh, GC
    BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1340 - 1346
  • [30] Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor
    Chen, YH
    Tukey, RH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) : 26261 - 26266
12345